Gene Query: RSRC1

Dataset Description Geneva Score
Insights into snoRNA biogenesis and processing from PAR-CLIP of snoRNA core proteins and small RNA sequencing 33.81
Topoisomerase 1 inhibition suppresses inflammatory genes and protects from death by inflammation 31.08
Topoisomerase 1 inhibition suppresses inflammatory genes and protects from death by inflammation (RNA-Seq) 31.08
RNA-Seq analysis of cSCC cells followed by siRNA-induced gene knockdown of AIM2. 20.49
Toxoplasma gondii remodels the cis-regulatory landscape of infected human host cells [RNA-seq] 19.47
Toxoplasma gondii remodels the cis-regulatory landscape of infected human host cells 19.47
The RNA binding protein IGF2BP3 promotes hematopoietic progenitor cell proliferation by targeting leukemogenic pathways 17.42
Identification of elevated A-to-I editing sites due to expression of an active ADAR3 mutant in human glioblastoma cells 16.33
Gene expression profiling of neural crest progenitor cultures derived from human embryonic stem cells carrying nonsense mutations in the Polycomb gene ASXL1 [HET] 16.14
PolyA-sequencing in Kelly and Kelly E9R neuroblastoma cells treated with THZ531 or DMSO 16.09
ILF2 Regulates RNA Splicing of DNA Damage Response Genes to Confer Poor Prognosis in 1q21-Amplified Multiple Myeloma 15.42
HITS-CLIP analysis uncovers a link between the Kaposi's sarcoma associated herpesvirus ORF57 protein and host pre-mRNA metabolism 15.41
Cleavage Factor Im as a key regulator of 3’ UTR length 14.59
MULTI-seq: Universal sample multiplexing for single-cell RNA sequencing using lipid-tagged indices 14.23
Sequencing Universal Human Reference RNA by Smart-seq and early barcoding library preparation methods 13.77
Global analysis of pre-mRNA subcellular localization upon splicing inhibition by spliceostatin A 11.68
The transcriptomic landscape of MAIT cell development in the thymus (C006 RNAseq data set) 11.54
Combined inhibition of STAT3 and DNA repair in palbociclib-resistant ER-positive breast cancer 11.1
Mitotically associated long non-coding RNA, MANCR regulates cell cycle in triple negative breast cancer cells  10.84
Gene expression profiles in response to proanthocyanidins in pancreatic cancer cells 10.73
Single cell analysis of HSV-1 infection reveals anti-viral and developmental programs are activated in distinct sub-populations with opposite outcomes 9.5
RNA-seq, ChIP-seq and single cell RNA-seq of human skin Langerhans cells 9.44
Cell-to-cell variation in defective virus expression and effect on host response during influenza virus infection 9.36
Genetic regulation of human adipose microRNA expression and its consequences for metabolic traits 9.1
Exploring transcriptomic landscapes in red cell populations, in their extracellular vesicles and on single cell level 9.09
The mechanism of HHT in treating acute myeloid leukemia on RNA level. 9.06
Transcriptome analysis of reticulated platelets reveals a prothrombotic profile 8.93
Transcriptome analysis of reticulated platelets reveals a prothrombotic profile [mRNA-Seq] 8.93
A damaged genome's transcriptional landscape through multilayered expression profiling around in situ-mapped DNA double-strand breaks 8.85
UV-Irradiation Induces a Noncoding RNA that Functionally Opposes the Protein Encoded by the Same Gene 8.85
Discovery of first-in-class reversible dual small molecule inhibitors against G9a and DNMTs with in vivo activity in hematological malignancies 8.64
Discovery of first-in-class reversible dual small molecule inhibitors against G9a and DNMTs with in vivo activity in hematological malignancies [RNA-Seq] 8.64
RNA-dependent RNA polymerase sequence specificities of capsnatching viruses are tailored to aid viral replication 8.41
Total RNA-seq in ALL-SIL upon TLX1 knockdown 8.4
Assessing the effect of SUPT4H1 RNAi on the transcription of a repeat-containing reporter construct 8.39
Generating Patterned Kidney Organoids for Studying Development and Diseases 8.09
Precise Gene Editing Preserves Hematopoietic Stem Cell Function Following Transient p53-Mediate DNA Damage Response 8.08
RNA sequencing to study transcriptomic changes in DLD-1 (colorectal adenocarcinoma) cells exposed to soft polyacrylamide matrices (~2 kPa and ~55 kPa) for short time scale of 90 minutes 8.06
Genome expression analysis of Lung Progenitors matured in the presence of constitutively active or pharmacologically inhibited Glycogen Synthase Kinase 3 7.91
Gene expression, methylome and splicing of THP-1 monocytic cells and THP-1-derived macrophage 7.86
High-throughput RNA sequencing on circular RNA profiles of human bladder cancer tissues and normal bladder tissues 7.82
Dynamics of the human and viral m6A RNA methylomes during HIV-1 infection of T cells 7.67
Enhancing human kidney organoid differentiation from pluripotent stem cells with high-throughput automation 7.62
Species-specific maturation profiles of human, chimpanzee and bonobo neural cells 7.36
RNA-Seq analysis of cSCC cells after siRNA-induced gene knockdown of lncRNA PRECSIT 7.33
Differential Protein Occupancy Profiling of the mRNA Transcriptome 7.24
Ribosomal footprinting of MDA_Ctrl and MDA_Arg overexpression cell lines 7.02
MicroRNA (miR)-211 loss promotes metabolic vulnerability and BRAF inhibitor sensitivity in melanoma 6.88
Effect of Ro 08-2750 treatment on gene expression of human leukemia cell lines MOLM13 and K562 6.71
Transcriptome-wide identification of splicing defects upon XAB2 knockdown 6.62
HNF1A deficiency impairs β-cell fate, granule maturation and function 6.57
Comprehensive comparative analysis of 5’ end RNA sequencing methods 6.48
Cockayne syndrome A and B proteins regulate the transcription arrest upon genotoxic stress through a ubiquitin/proteasome degradation process 6.37
Cockayne syndrome A and B proteins regulate the transcription arrest upon genotoxic stress through a ubiquitin/proteasome degradation process (RNA-seq) 6.37
Transcriptomics of human macrophages upon infection with Legionella pneumophila and two isogenic mutants, LamA and AnkH using RNA-seq 6.29
Regulation of mRNA half-life by an inhibitor of human decapping enzyme Dcp2 following transcription shutoff in HEK293T cells 6.25
Resistance to BET inhibitor leads to new therapeutic vulnerabilities in castration resistant prostate cancer 6.21
Codon usage optimization in pluripotent embryonic stem cells [tRNA sequencing] 6.2
The MLL-AF9 and MLL-AF4 oncofusion proteins bind a distinct enhancer repertoire and target the RUNX1 program in MLLr AML 6.19
circRNA profile in hypopharyngeal cancer 6.17
MeRIP sequencing reveals angiogenic properties of vascular endothelial cells 5.95
scRNASeq analysis of cycling cardiomyocytes 5.93
Transcriptional profile of human STAT1-/- fibroblasts expressing IFI6 or empty control vector 5.76
Stably-paused genes revealed through inhibition of transcription initiation by the TFIIH inhibitor Triptolide 5.7
Short and Long RNA sequencing of human mature erythrocytes 5.7
Transcriptome of EMT induced MCF10A cells by TGFb treatment or SNAIL S6A expression. 5.68
Effect of PRDM11 depletion in U2932 cells 5.63
Increased Serine and One Carbon Pathway Metabolism by PKCl/i Deficiency Promotes Neuroendocrine Prostate Cancer 5.58
Increased Serine and One Carbon Pathway Metabolism by PKCl/i Deficiency Promotes Neuroendocrine Prostate Cancer [RNA-seq] 5.58
Inhibition of TNBC metastasis by Gpx1 5.58
Identification of renal resident macrophages across species 5.52
FMRP-associated MOV10 facilitates and antagonizes miRNA-mediated regulation 5.51
Effects of Cardiac Glycosides on RNA Expression in Prostate Cancer LNCaP-abl Cells 5.5
Characterization of human CDK12 and CDK13 in the regulation of RNA processing 5.45
A potent and selective small-molecule degrader of STAT3 achieves complete tumor regression in vivo 5.39
Tracking distinct RNA populations using efficient and reversible covalent chemistry 5.38
Global transcriptional changes in the JJN3 myeloma cell line that occur as a result of treatment with 2 pyrrolobenzodiazepine (PBD) monomers 5.37
Single-cell RNA sequencing-based CRISPRi screening resolves molecular drivers of early human endoderm development [set 1] 5.32
Defining the Transcriptional Landscape during Cytomegalovirus Latency with Single-Cell RNA Sequencing 5.31
Ribosomal footprinting of MDA-Parental and MDA-LM2 5.29
Genome-scale screens identify JNK/JUN signaling as a barrier for pluripotency exit and endoderm differentiation 5.26
LSD1 pharmacological inhibition in SET-2 containing wild type and mutant LSD1 5.25
LSD1 pharmacological inhibition in SET-2 containing wild type and mutant LSD1 [RNA-Seq] 5.25
Transcriptional profiling of microglia; current state of the art and future perspectives 5.19
CDK12 catalytic activity is rate-limiting for RNAPII processivity on core DNA replication genes and G1/S progression 5.19
mRNA cap methyltransferase, RNMT-RAM, promotes RNA pol II transcription 5.15
Messenger RNA expression after silencing or inhibition of MEN1in MCF-7 breast cancer cells 5.15
Gene expression in PANC1 cells treated with Rakicidin 5.13
EZH2 inhibitor efficacy in non-Hodgkin lymphoma does not require suppression of H3K27 mono-methylation 5.11
EZH2 inhibitor efficacy in non-Hodgkin lymphoma does not require suppression of H3K27 mono-methylation [RNA-Seq] 5.11
MEF2C phosphorylation is required for chemotherapy resistance in acute myeloid leukemia 5.1
Ribosomal footprinting of CN34-Parental and CN34-LM1a 5.06
Triplet nucleotide repeat-based siRNAs are highly toxic to cancer cells 5.03
Overexpression of NFIB and YBX1 in MCF-7 cells 5.03
Next Generation Sequencing upon siRNA-mediated knockdown of EIF5A in MCF-7 cells. 5.03
Proteinase-Activated Receptor 4 (PAR4) mediates cell membrane blebbing in a Gaq/11, Gai independent, RhoA and ß-arrestin-dependent manner. 5.01
Histone demethylase LSD1 is required for germinal center formation and BCL6 driven lymphomagenesis 5.0
Transcriptional changes in lymphoma cells induced by LSD1 depletion 5.0
Global Mapping of Human RNA-RNA Interactions 4.98
DART-seq: an antibody-free method for global m6A detection 4.95
Epigenome-wide Effects of Vitamin-D on Bronchial Epithelial Cells using ATAC-Seq and RNA-seq 4.92
Knockdown of ADNP in HCT116 colon cancer cells 4.9
Unique features and clinical importance of acute alloreactive immune responses 4.89
Hierarchy of mono- and bi-allelic TP53 alterations in Multiple Myeloma cell fitness 4.87
The hematopoietic master transcription factor PU.1 requires its interaction with the SWI/SNF remodeler to access chromatin de novo 4.86
The hematopoietic master transcription factor PU.1 requires its interaction with the SWI/SNF remodeler to access chromatin de novo [RNA-seq] 4.86
Human Nonsense-Mediated RNA Decay Initiates Widely by Endonucleolysis and Targets snoRNA Host Genes 4.78
RNA expression analysis of neuroblastoma cell lines treated with epigenetic drugs 4.71
Glutaminolysis is a metabolic dependency in FLT3 ITD Acute Myeloid Leukemia unmasked by FLT3 Tyrosine Kinase Inhibition 4.65
RNA-Seq following PCR-based sorting reveals rare cell transcriptional signatures 4.64
Fibroblasts in cholesteatoma activate osteoclasts. 4.58
Oncogenic MYC induces a dependency on the spliceosome in human cancer 4.58
Activation of HOTTIP lncRNA perturbs HSC function leading to AML like disease 4.57
CHD1 loss sensitizes prostate cancer to DNA damaging therapy by promoting error-prone double-strand break repair 4.52
Enhancement of Arterial Specification in Human Pluripotent Stem Cell Cultures Promotes Definitive Hematoendothelial Program with Broad Myelolymphoid Potential 4.49
Campylobacter concisus pathotypes induce distinct global responses in intestinal epithelial cells 4.46
Genome-wide maps of H3K36me3 in ccRCC and RNA-seq of matched nephrectomy samples 4.46
RNA sequencing of matched nephrectomy samples [RNA-seq] 4.46
Response of HEK293 Freestyle cells to 36 h of culture in Zn(II)-depleted Freestyle medium 4.41
Dual inhibition of HDMX and HDM2 as a Therapeutic Strategy in Leukemia 4.4
The role of PHF19 in promoting H3K27me3 deposition in multiple myeloma 4.35
The role of PHF19 in promoting H3K27me3 deposition in multiple myeloma (RNA-Seq) 4.35
Targeting MTHFD2 in Acute Myeloid Leukemia 4.35
Global analysis of enhancer targets: Mosaic-seq 4.35
Gene expression alterations associated with acquired-resistance to the CDK4/6 inhibitor palbociclib [Palbociclib resistance_RNASeq] 4.29
ZFR coordinates crosstalk between RNA decay and transcription in innate immunity 4.28
RNA expression following TMPRSS11B overexpression or depletion 4.26
Improving fibroblast characterization using single-cell RNA sequencing: an optimized tissue disaggregation and data processing pipeline 4.25
SMN deficiency in spinal muscular atrophy causes widespread intron retention and DNA damage 4.21
GIST cell cycle dysregulation is required for progression to high-risk disease but not for resistance to kinase inhibitors 4.21
Nucleotide stress induction of HEXIM1 suppresses melanoma by modulating cancer cell-specific gene transcription 4.18
Expression level comparison under dividing and quiescent states in human primary fibroblasts 4.17
The E3 ubiquitin ligase HectD1 suppresses EMT and metastasis by targeting the +TIP protein ACF7 for degradation 4.17
DNA breaks and chromatin structural changes enhance the transcription of Autoimmune Regulator target genes [RNA-Seq] 4.14
DNA breaks and chromatin structural changes enhance the transcription of Autoimmune Regulator target genes 4.14
TWIST1-induced microRNA-424 drives an intermediate epithelial-to-mesenchymal transition that opposes metastasis 4.14
MenSCs inhibit HCC growth through oncogenic pathway suppression via regulating 5-hmC in enhancer elements [RNA-seq] 4.1
MenSCs inhibit HCC growth through oncogenic pathway suppression via regulating 5-hmC in enhancer elements 4.1
Transcriptome-wide analysis of the role of HTLV-1 Tax PBM in T-Cells from infected humanized-mice (hu-Mice) 4.09
Comparison of expression profiles of APP-depleted prostate cancer cells (LNCaP) 4.07
N6-methyladenosine mRNA marking promotes selective translation of regulons required for human erythropoiesis [RNA-Seq] 4.07
A Unique Epigenomic Landscape Defines Human Erythropoiesis 4.06
A Unique Epigenomic Landscape Defines Human Erythropoiesis (RNA-seq) 4.06
RNA-Seq to assess the transcriptional effects of G quadruplex stabilization by the G4 ligand PhenDC3 in HT-1080 cells 4.04
Dynamic epigenetic remodeling underlies microRNA-mediated transdifferentiation of human adult fibroblasts into neuronal subtypes 4.03
Multiple mechanisms disrupt let-7 miRNA biogenesis and function in neuroblastoma 4.01
TimeLapse-seq: adding a temporal dimension to RNA sequencing through nucleoside recoding 3.98
RNAseq to determine gene expression changes following depletion of SETDB1 in THP-1 AML Cells 3.98
Transcriptomic analyssis following EHMT1/2 inhibition 3.97
CRISPR adenine and cytosine base editors with reduced RNA off-target activities 3.95
CRISPR adenine and cytosine base editors with reduced RNA off-target activities [CBE] 3.95
Transcriptomics profiling of Alzheimer’s disease reveal novel molecular targets 3.91
Nickel induced transcriptional changes persist post exposure through epigenetic reprograming 3.9
Gene expression profiling of human MSC-educated macrophages vs. classical macrophages from bone marrow and blood 3.88
Isolation and Transcriptome Analyses of Human Erythroid Progenitors: BFU-E and CFU-E 3.88
Genome-wide CRISPR-Cas9 screen identifies functionally relevant microRNAs in AML 3.87
Expression profile of wild type (WT) vs miR-155-/- in FLT3-ITD+ AML (MV4-11) cell lines 3.87
CXCR4 regulates extra-medullary myeloma through epithelial-mesenchymal transition-like transcriptional activation 3.85
Transriptional profiling upon heat shock and recovery in cells deficient for FBXW7 and their wild type counterpart. 3.82
FBXW7 modulates stress response by post-translational modification of HSF1 3.82
A pooled single-cell genetic screen identifies regulatory barriers in the continuum of the epithelial-to-mesenchymal transition 3.82
Integrating single-cell transcriptomic data across different conditions, technologies, and species 3.82
Inducible three-factor direct reprogramming to nephron progenitors using piggyBac transposons 3.81
Virus-like vesicles of Kaposi’s Sarcoma-Associated Herpesvirus activate lytic replication through triggering differentiation signaling 3.8
Virus-like vesicles of Kaposi’s Sarcoma-Associated Herpesvirus activate lytic replication through triggering differentiation signaling (mRNA) 3.8
Premature polyadenylation-mediated loss of stathmin-2 is a hallmark of TDP-43-dependent neurodegeneration 3.8
Genome-wide chromatin analysis of Ewing sarcoma 3.79
Genome-wide chromatin analysis of Ewing sarcoma (RNA-seq) 3.79
lncRNA-PCAT1 knockdown effect on the gene expression of androgen independent LNCaP (LNCaP-AI) cell line 3.73
Coronary Artery Disease Associated Transcription Factor TCF21 Regulates Smooth Muscle Precursor Cells that Contribute to the Fibrous Cap 3.72
Single-cell transcription profiling in KS1 patient iPSCs and NPCs 3.71
Human embryonic stem cell, chimpanzee induced pluripotent stem cell, orangutan induced pluripotent stem cell, rhesus embryonic stem cell, and their derived cortical organoid RNA-seq 3.69
Proteolytic cleavage by taspase1 and the regulation of the stability of MLL1 3.67
Single-cell analysis reveals stochastic regulation of type I IFN production by plasmacytoid dendritic cells and identifies host-derived environmental cues as amplifier of type I IFN production 3.66
HNRNPM-regulated splicing dependencies in prostate cancer [RNA-Seq] 3.65
HNRNPM-regulated splicing dependencies in prostate cancer 3.65
PAK4 suppresses RELB to prevent senescence-like growth arrest in breast cancer 3.65
Integrin signaling regulates YAP/TAZ to control skin homeostasis 3.65
The Developmental Heterogeneity of Human Natural Killer Cells Defined by Single-cell Transcriptome 3.64
Study functions of ADAR proteins using next generation sequencing of genome and transcriptome 3.64
ZBTB48 is both a vertebrate telomere-binding protein and a transcriptional activator 3.62
ZBTB48 is both a vertebrate telomere-binding protein and a transcriptional activator [RNA-seq] 3.62
Sequencing of ponatinib-resistant LC-2/ad derivatives (PR1 and PR2) and parental LC-2/ad cells 3.62
PAX3-FOXO1 requires BRD4 to drive oncogene addiction in RMS cells [RNA-seq] 3.6
Epigenetic Lanscape and BRD4 Transcriptional Dependency of PAX3-FOXO1 Driven Rhabdomyosarcoma 3.6
HLA peptides derived from tumor antigens induced by inhibition of DNA methylation for development of drug-facilitated immunotherapy 3.58
Discovery and verification of liver cancer marker genes and variable scission based on second-generation sequencing data analysis 3.58
Single-cell Transcriptomic Atlas of the Human Retina Identifies Cell Types Associated with Age-Related Macular Degeneration [Microfluidics] 3.55
The effect of Abl kinases on non-small cell carcinoma global transcriptome 3.53
Single-cell RNA sequencing-based CRISPRi screening resolves molecular drivers of early human endoderm development 3.49
Targeting Chromatin Regulators Inhibits Leukemogenic Gene Expression in NPM1 Mutant Leukemia 3.47
Human Treg IL-12 stimulation 3.45
A quantitative chemotherapy genetic interaction map identifies new factors associated with PARP inhibitor resistance 3.45
The effect of PPARG inhibition on human angiomyolipoma cells 3.43
FBP2 inhibits sarcoma progression by restraining mitochondrial biogenesis 3.43
Next Generation Sequencing Facilitates Quantitative Analysis of UVB(20mJ/cm2 and 40mJ/cm2) exposed and untreated HaCaT keratinocytes Transcriptomes 3.42
Transcription control by the ENL YEATS domain in acute leukemia [RNA-seq] 3.41
Transcription control by the ENL YEATS domain in acute leukemia 3.41
Analysis of transcriptional regulation by Myt1 and Myt1l 3.4
Compared performance of Affymetrix HTA arrays and Illumina RNAseq for the analysis of tumours 3.4
Compared performance of Affymetrix HTA arrays and Illumina RNAseq for the analysis of tumours [RNA-seq] 3.4
A SRp55-regulated alternative splicing network controls pancreatic beta cell survival and function 3.4
Cohesin and CTCF Differentially Affect the Chromatin Architecture and Gene Expression in Human Cells 3.39
Circular RNAs are down-regulated in KRAS mutant colon cancer cells and can be transferred to exosomes 3.37
MYC dependent mRNA translation shapes gene expression and cell biology 3.37
Single-cell Map of Diverse Immune Phenotypes in the Breast Tumor Microenvironment - 5' RNA sequencing and TCR sequencing 3.35
Rational targeting of cooperating layers of the epigenome yields enhanced therapeutic efficacy against AML 3.29
Nuclear Parkin Regulates Transcriptional Response during Hypoxia 3.29
CD95L derived si- and shRNAs kill cancer cells through an RNAi mechanism by targeting survival genes [shL3.shR6.RNAseq.lg] 3.27
Differential gene expression of static and intermittent compressive force treated human periodontal ligament cells 3.27
Transcriptome wide analysis of translation efficiency in MCF7 cells using polysome profiling with and without eIF4A inhibition by hippuristanol treatment 3.27
Active translatome profiling with RiboLace in MCF7 cells 3.26
RNA sequencing with KSHV infection and enrichment for circular RNAs 3.25
An Argonaute phosphorylation cycle promotes microRNA-mediated silencing [whole transcriptome RNA-seq] 3.24
Low H3K27me3 and DNA hypomethylation define poorly prognostic pediatric posterior fossa ependymomas 3.23
ZRANB2 and SYF2 mediated splicing programs converging on ECT2 are involved in breast cancer cell resistance to doxorubicin 3.22
Novel Form of JARID2 is Required to Regulate Differentiation in Keratinocytes. 3.2
Integrative analysis of mRNA and lncRNA profiles identified pathogenetic lncRNAs in esophageal squamous cell carcinoma 3.18
N6-methyladenosine mRNA marking promotes selective translation of regulons required for human erythropoiesis[Ribosome Profiling] 3.18
Trisomy of a ‘Down syndrome critical region’ globally amplifies transcription via HMGN1 overexpression 3.18
WRN knockout effects upon gene expression in SW48 and OVK18 3.17
Post-transcriptional manipulation of TERC reverses molecular hallmarks of telomere disease 3.16
Elongation Factor TFIIS Prevents Transcription Stress and R-Loop Accumulation to Maintain Genome Stability [ RNA-seq] 3.16
Elongation Factor TFIIS Prevents Transcription Stress and R-Loop Accumulation to Maintain Genome Stability 3.16
SPOP mutation confers intrinsic BET inhibitor resistance in prostate cancer 3.14
The Short Isoform of BRD4 Promotes HIV-1 Latency by Engaging Repressive SWI/SNF Chromatin Remodeling Complexes 3.14
Functional Importance of eRNAs for Estrogen-dependent Gene Transcriptional Activation 3.12
Comparison between THP-1 cells obtained from either ATCC or DSMZ biorepository 3.1
TNFα Signaling Exposes Latent Estrogen Receptor Binding Sites in Breast Cancer Cells [GRO-seq] 3.09
TNFα Signaling Exposes Latent Estrogen Receptor Binding Sites in Breast Cancer Cells 3.09
Expanding the Nucleoside Recoding Toolkit: Revealing RNA Population Dynamics with 6-thioguanisine 3.07
ICE1 promotes the link between splicing and nonsense-mediated mRNA decay 3.07
High throughput characterization of the m6A demethylase FTO by CLIP and RNAseq 3.03
Multiplexed engineering and analysis of endogenous enhancer activity in single cells: Mosaic-Seq of beta-globin locus (separate infection) 3.02
RNA-Seq study of Cell lines rendered resistant to idelalisib and ibrutinib 3.01
Integrated multi-omics approach reveals a role of ALDH1A1 in lipid metabolism in human colon cancer cells 2.99
Characterization of sperm lncRNA and its differently expression in the sperm of asthenozoospermic patients 2.98
Tristetraprolin disables prostate cancer maintenance by impairing proliferation and metabolic function 2.98
Gene expression profiles of tumor-infiltrating CD8 T cells in hepatocellular carcinoma 2.98
A prostate cancer chromatin interaction map 2.97
Single-cell RNAseq analysis of the empty and i8TF cell lines after 3 days of BL-CFC culture 2.96
Single cell transcriptomics reveals new insights on the dynamical function of transcription factors during blood stem and progenitor cell formation 2.96
Profile of gene expression in U87-MG xenografts expressing control vector (V0), the ubiquitin ligase KPC1 or the p50 subunit of the NF-kB transcription factor, using RNASeq analysis of transcripts mapped independently to the human and murine genomes 2.92
Platelet Transcriptome Profiling in HIV and ABCC4 as a Biomarker of Platelet Activity 2.91
Illumina Total RNA-seq in HeLa 2.89
BET-Bromodomain Inhibitors Engage The Host Immune System And Regulate Expression Of The Immune Checkpoint Ligand PD-L1 2.87
BET-Bromodomain Inhibitors Engage The Host Immune System And Regulate Expression Of The Immune Checkpoint Ligand PD-L1 [3mRNA-seq] 2.87
AhR activity directs BRAF inhibitors resistance in metastastic melanoma 2.86
RNA-Seq with and without RNase treatment in PCa cell lines 2.86
Comparison of single-cell transcriptomics quality between unfixed cells and cells that were fixed and mock stained according to the RAID procedure 2.82
Transient stabilization, rather than inhibition of MYC amplifies extrinsic apoptosis and therapeutic responses in refractory B-cell lymphoma 2.82
Human SETMAR is a DNA sequence-specific histone-methylase with a broad effect on the transcriptome 2.82
Opposing Effects of Cyclooxygenase-2 (COX-2) on Estrogen Receptor β (ERβ) Response to 5α-reductase Inhibition in Prostate Epithelial Cells 2.81
CBFβ-MYH11 fusion blocks hematopoietic differentiation via repression of a GATA2 gene program 2.79
DHX9 suppresses spurious RNA processing defects originating from the Alu invasion of the human genome [uvCLAP CLIP-seq] 2.79
ETS1 induction by the omental microenvironment promotes ovarian cancer metastasis [RNA-Seq] 2.79
ETS1 induction by the omental microenvironment promotes ovarian cancer metastasis 2.79
Gene expression analysis of CD4+ and CD4- ILC1 subsets by RNAseq 2.75
A cell-permeable stapled peptide inhibitor of the estrogen receptor/coactivator interaction 2.72
Smad5 acts as an intracellular pH messenger and maintains bioenergetic homoeostasis 2.72
Sensing self and nonself circular RNAs 2.7
Global transcriptome analysis of HAP1 cells 2.68
High-throughput single cell transcriptome analysis and CRISPR screen identify key β cell-specific disease genes 2.67
Genome-wide analysis of the Integrator complex (HTS) 2.67
Genome-wide analysis of the Integrator complex 2.67
Transcriptional profile of human STAT1-/- fibroblasts expressing LY6E or empty control vector 2.64
MiR-CLIP capture of a miRNA targetome uncovers a lincRNA H19-miR-106a interaction [III] 2.63
Single-cell analysis of human kidney organoids 2.62
RNA-seq analysis of uveal melanoma cells treated with FR900359 2.61
Translating transcriptome of cancer cells in situ in mesenchymal-rich tumor microenvironment 2.61
Measuring the effect of MYC on transcription during the DNA double-strand break response by RNA-seq of newly synthesized transcripts 2.61
Pseudotime Ordering of Single Human Beta-Cells Reveals States of Insulin Production and Unfolded Protein Response 2.58
Next generation sequencing of small RNAs isolated from exosomes in human semen 2.57
LIN28A Over-expression RNAseq 2.56
Mapping interactions for the TNIP2 hub protein 2.55
Isolation and Functional Interrogation of Adult Human Prostate Epithelial Stem Cells at Single Cell Resolution 2.53
U2AF1 mutations alter splice site recognition in hematological malignancies 2.49
Chromatin mapping and single-cell immune profiling defines the temporal dynamics of ibrutinib drug response in chronic lymphocytic leukemia [scRNA-seq] 2.49
Chromatin mapping and single-cell immune profiling defines the temporal dynamics of ibrutinib drug response in chronic lymphocytic leukemia 2.49
RUNX1-ETO and RUNX1-EVI-1 differentially program the chromatin landscape in t(3;21) and t(8;21) AML but share global C/EBP-alpha dysfunction (RNA-Seq) 2.45
RUNX1-ETO and RUNX1-EVI-1 differentially program the chromatin landscape in t(3;21) and t(8;21) AML but share global C/EBP-alpha dysfunction 2.45
mTORC1 balances cellular amino acid supply with demand for protein synthesis through post-transcriptional control of ATF4 2.4
METTL3 and WTAP 2.38
Wide-scale analysis of alternative polyadenylation (APA) associated with proliferation and transformation using 3'-Seq 2.35
Differential expression in LNCaP cells expressing the wild-type androgen receptor (AR-WT) or the ligand-independent AR-V7 splice variant 2.34
mRNA differential expression in LNCaP cells expressing the wild-type androgen receptor (AR-WT) or the ligand-independent AR-V7 splice variant 2.34
Exploiting Prmt5-orchestrated intron detention signatures to treat splicing-addicted malignant glioma tumors 2.33
ATF4 inhibition by p62 represses stromal metabolic reprogramming and tumorigenesis II 2.33
Global Long Terminal Repeat activation participates in establishing the unique gene expression program of classical Hodgkin Lymphoma [Primary RNA-Seq] 2.28
RNA sequencing of human mammary epithelial cells 2.27
N6-methyladenosine Recruits HNRNPG for Alternative Splicing Regulation 2.26
Interleukin-1β induces mitochondrial DAMP production to activate STING-dependent innate immune programs 2.26
The ALK downregulated target gene HBP1 and repressor of MYCN activity as synergistic target for combined PI3K/HDAC inhibition 2.24
The ALK downregulated target gene HBP1 and repressor of MYCN activity as synergistic target for combined PI3K/HDAC inhibition [RNA-Seq] 2.24
Expression profiling of etoposide-induced senescent cells 2.22
Next generation sequencing of the transcriptome in MCF-7 cells with/without SRA knockdown 2.21
Systematic Functional Dissection of Common Genetic Variation Affecting Red Blood Cell Traits [mRNA-Seq] 2.2
Systematic Functional Dissection of Common Genetic Variation Affecting Red Blood Cell Traits 2.2
Single cell analysis of smooth muscle cell phenotypic modulation in vivo during disease in mice and humans 2.18
Single cell analysis of smooth muscle cell phenotypic modulation in vivo during disease in mice and humans [human scRNA-seq] 2.18
mRNA gene expression profiling in a human AML cell line treated with small molecule inhibitors that impact different RNA polymerase transcription complexes, or their combination, in comparison to a global DNA-damaging anthracycline compound 2.17
RNA-seq of human foreskin fibroblast cells lacking RB, p130, and p107 treated with doxorubicin. 2.16
Radiomic and gEnomic approaches for the enhanced DIagnosis of REnal Cancer (REDIRECt): A translational pilot study 2.15
Structural basis for human respiratory syncytial virus NS1-mediated modulation of host responses 2.15
Impact of Escherichia coli K12 and O18 on human platelets: effects on platelet activation, spliced platelet RNAs and proteins 2.13
Dynamic 3D chromosomal landscapes in acute leukemia 2.12
Dynamic 3D chromosomal landscapes in acute leukemia [RNA-Seq] 2.12
Global transcriptional changes in U87MG glioblastoma cells upon shRNA-mediated TRIM52 knockdown 2.1
NR4A1 Inhibition Synergizes with Ibrutinib in Killing Mantle Cell Lymphoma Cells 2.09
Regulation of PRMT5-MDM4 axis is critical in the response to CDK4/6 inhibitors in melanoma 2.07
pSILAC mass spectrometry reveals ZFP91 as novel IMiD dependent substrate of the CRL4CRBN ligase 2.06
Enhancer Sequence Variants and Transcription Factor Deregulation Synergize to Construct Pathogenic Regulatory Circuits in B Cell Lymphoma 2.06
Enhancer Sequence Variants and Transcription Factor Deregulation Synergize to Construct Pathogenic Regulatory Circuits in B Cell Lymphoma (RNA-Seq) 2.06
MicroRNA-28 replacement for non-Hodgkin lymphoma therapy 2.05
LKB1, Salt-Inducible Kinases, and MEF2C are linked dependencies in acute myeloid leukemia 2.03
LKB1, Salt-Inducible Kinases, and MEF2C are linked dependencies in acute myeloid leukemia (RNA-Seq) 2.03
Comprehensive Epigenetic Landscape of Rheumatoid Arthritis Fibroblast-like Synoviocytes 2.02
Comprehensive Epigenetic Landscape of Rheumatoid Arthritis Fibroblast-like Synoviocytes [RNA-seq] 2.02
The cohesin release factor WAPL restricts chromatin loop extension. 1.98
The cohesin release factor WAPL restricts chromatin loop extension. [RNA-Seq] 1.98
Luminal subtype-specific circRNAs in breast cancer cells by a novel tool for external data analysis. 1.97
Changes in CD34 and Erythroid Progenitor Transcriptome After RUNX3 Kock-down 1.96
Ewing sarcoma resistance to SP-2509 is not mediated through KDM1A/LSD1 mutation I 1.94
Role of cervicovaginal microbiota in genital inflammation 1.93
Cistromic re-programming by truncating GATA3 mutations promotes mesenchymal transformation in vitro, but not mammary tumour formation in mice [RNA-seq] 1.91
Cistromic re-programming by truncating GATA3 mutations promotes mesenchymal transformation in vitro, but not mammary tumour formation in mice 1.91
RNA G-quadruplexes mark repressive upstream open reading frames in human mRNAs 1.91
Pain-driven transcriptome changes in synovium of knee osteoarthritis patients 1.9
RNA-Seq data of NCI-H82 cells expressing a Dox-On pRB (pTripZ RB1) grown in the presence or absence of DOX and then treated with vehicle or AZD2811. 1.87
Targetting super enhancer associated oncogenes in esophageal squamous cell carcinoma 1.86
Targetting super enhancer associated oncogenes in esophageal squamous cell carcinoma [RNA-seq] 1.86
RNA-seq of HEK293T cells overexpressing TET1-FL or TET1-ALT 1.85
Cooperation of Nutlin-3a and a Wip1 inhibitor to induce p53 activity 1.84
Next Generation Sequencing Facilitates Quantitative Analysis of Wild Type and PVT1 Knockdown by CRISPRi in MDA-MB-231 human breast cancer cell line 1.8
Promoter of lncRNA gene *PVT1* is a tumor suppressor DNA element 1.8
The identification of RBM47 binding sites and RBM47-dependent alternative splicing events in brain metastatic breast cancer cells 1.77
Identification of alternatively spliced transcripts in brain metastatic derivatives of MDA-MB-231 breast cancer cells in response to RBM47 expression 1.77
Transcriptome analysis of SH-SY5Y cells after knockdown of circSLC45A4 1.77
Simultaneous quantification of antibody-RNA conjugates and the transcriptome from fixed cells by RAID 1.74
RNAseq of human monocyte cell line (U937-Cas9) WT or IRF2KO 1.73
Genome-wide profile of cJun and p27 and gene expression profile in breast cancer cells 1.69
Gene expression profile in breast cancer cells 1.69
PTHrP overexpression in MCF7 cells 1.66
Discovering human diabetes-risk gene function with genetics and physiological assays 1.64
MEF2C phosphorylation is required for chemotherapy resistance in acute myeloid leukemia [inhibitor MRT199665] 1.63
RNA transcriptome sequencing analysis of SGC-7901 cells transfected with ENST00000431060 shRNA or control shRNA 1.63
SLAM-seq defines direct gene-regulatory functions of the BRD4-MYC axis 1.6
SLAM-seq defines direct gene-regulatory functions of the BRD4-MYC axis [Quant-Seq] 1.6
ARID1A is a critical regulator of luminal identity and therapeutic response in oestrogen receptor-positive breast cancer (RNA-Seq) 1.6
Single-cell RNA-seq reveals differentiation of bona fide human pDCs and cDC1s in cultures of cord blood CD34+ progenitors, and a newly identified terminal differentiation step of cDC1s 1.59
Comparative total RNA and mRNA sequencing and systems analysis reveals nascent transcriptional response to early HIV-1 infection in a CD4+ T cell line 1.59
Nucleotide stress induction of HEXIM1 suppresses melanoma by modulating cancer cell-specific gene transcription [RNA-Seq2] 1.58
Identification of HOXB13 target genes responsive to BET inhibitors 1.53
The cohesin complex prevents Myc-induced replication stress 1.5
Genome-wide MAF1-dependent regulation of RNA polymerase III transcription 1.5
Genome-wide MAF1-dependent regulation of RNA polymerase III transcription [RNA-Seq] 1.5
Transcriptome analysis in a radiosensitive and a radioresistant cell line after ionizing radiation 1.49
Tracing transcriptome profiles of human oocyte cultured by growth hormone or not in vitro by single cell RNA-seq 1.47
Deletions in the ATAD3 gene cluster cause cerebellar developmental defects with mitochondrial DNA abnormalities owing to local cholesterol insufficiency 1.47
Transcriptomic analysis to functionally map the intrinsically disordered domain of EWS/FLI [Experiment 1] 1.46
Next Generation Sequencing upon siRNA-mediated knockdown of DRAIC in MCF-7 cells. 1.46
Oncogenic Notch promotes long-range regulatory interactions within hyperconnected 3D cliques 1.45
KANK1 inhibits cell growth by inducing apoptosis though regulating CXXC5 in human malignant peripheral nerve sheath tumors 1.44
Clonally expanded CD8 T cells patrol Alzheimer's cerebrospinal fluid [TEMRA] 1.44
Clonally expanded CD8 T cells patrol Alzheimer's cerebrospinal fluid 1.44
BMS-470539 on human synovial fibroblasts 1.43
Nickel exposure induces persistent mesenchymal phenotype in human lung epithelial cells through epigenetic activation of ZEB1 1.43
RNA-seq and ChIP-seq analysis of BMI1 or RING1B-silenced prostate cancer cells C4-2 1.38
Trisomy of a ‘Down syndrome critical region’ globally amplifies transcription via HMGN1 overexpression [NALM6 RNA-Seq] 1.37
N6-methyladenosine (m6A) profiling of EndoC-bH1 cell line and RNA seq of Mettl14 knockout mice beta cell 1.37
Small molecule inhibition of ERK dimerization prevents tumorigenesis by Ras-ERK pathway oncogenes 1.37
Expression analysis of PC3 cells treated with scramble AON or AON directed against MBNL1 1.36
Functional significance of the HIV-1 Tat signature amino acid residues 1.34
NSD2 overexpression links drives clustered chromatin and transcriptional changes in a subset of insulated domains of insulated domains 1.32
Generation and persistence of human tissue-resident memory T cells in lung transplantation 1.32
Genome-wide expression analysis of young, senescent and p38MAPK-inhibitited senescent human fibroblasts. 1.31
Cap-specific terminal N6-methylation of RNA by an RNA polymerase II-associated methyltransferase. 1.3
Dissecting cell composition and cell-cell interaction network of human disease heart tissue by single-cell sequencing 1.27
Repression of stress-induced LINE-1 expression protects cancer cell populations from lethal drug-exposures 1.27
Repression of stress-induced LINE-1 expression protects cancer cell populations from lethal drug-exposures [RNA-Seq] 1.27
Antioxidant metabolism in activated CD8+ T cells regulates stem-like human memory T cell formation and anti-tumor immunity 1.19
Characterizing the contrasting roles of JMJD3 and UTX histone demethylases in T cell acute lymphoblastic leukemia [GSKJ4_RNA-seq] 1.19
Low carbohydrate diet study for non-alcoholic fatty liver disease patients 1.17
NOTCH1 activation in breast cancer confers sensitivity to inhibition of SUMOylation 1.16
TOP2B disturbed the quality of human oocytes with advanced maternal age 1.16
The transition from proliferation to quiescence in glioblastoma stem-like cells requires Ca2+ signaling and mitochondria remodeling 1.15
Human muscle-derived CLEC14A-positive cells regenerate muscle independent of PAX7 1.14
polyA RNA Sequencing Analysis of HTR-8/SVneo cells after lnc-SLC4A1-1 overexpression 1.14
RNA-seq on Enasidenib or DMSO Treated CD71+ Cells from Umbilical Cord Blood (UCB) 1.14
KRASG12C inhibition produces a driver-limited state revealing collateral dependencies 1.11
Evidence for rRNA 2'-O-methylation plasticity: control of intrinsic translational capabilities of human ribosomes 1.1
Mapping of DHT-responsive or -independent AR-binding sites induced by activated Src in prostate cancer cell lines [RNA-seq] 1.1
Mapping of DHT-responsive or -independent AR-binding sites induced by activated Src in prostate cancer cell lines 1.1
Efficient and precise editing of endogenous transcripts with SNAP-tagged ADARs 1.09
COMBINING BET AND MEK INHIBITORS SYNERGISTICALLY TARGETS NRAS MUTANT MELANOMA 1.08
Osmostress induced changes of chromatin architecture and transcription in mammalian cells 1.08
Osmostress induced changes of chromatin architecture and transcription in mammalian cells [RNA-Seq, HiC] 1.08
Migration through a small pore disrupts inactive chromatin organisation in neutrophil-like cells [RNA-seq] 1.08
RNA-seq and Hi-C sequencing of neutrophil-like cells migrated through large or small pores 1.08
Cellular recruitment by podocyte-derived pro-migratory factors in assembly of the human renal filter 1.06
Identification and characterization of circular RNAs as a new class of putative biomarkers in human blood 1.05
A monocyte gene expression signature in the early clinical course of Parkinson’s disease 1.04
Coordinate regulation of alternative pre-mRNA splicing events by the human RNA chaperone proteins hnRNPA1 and DDX5 1.01
Mutational landscape of aggressive natural killer-cell leukemia and drug profiling highlight JAK-STAT signaling as a therapeutic target in NK-cell malignancies 1.01
Remodeling of Ago2-mRNA interactions upon cellular stress reflects miRNA complementarity and correlates with altered translation rates 1.0
Remodeling of Ago2-mRNA interactions upon cellular stress reflects miRNA complementarity and correlates with altered translation rates (part 4) 1.0
O-glcnAc reprograms cellular energetics 0.98
ATF7IP-mediated stabilization of the histone methyltransferase SETDB1 is essential for heterochromatin formation by the HUSH complex 0.96
Assessing the impact of loss of ATF7IP and SETDB1 on the transcriptome 0.96
A Primate lncRNA Mediates Notch Signaling During Neuronal Development by Sequestering miRNA [SHSY5Y cells] 0.96
ZNF599 and DNMT3A coordinately control nuclear envelope organization by repression of SUN4 expression 0.94
RNA sequencing of primary human platelets and in vitro cell lines 0.86
High-throughput RNA sequencing on circular RNA profiles of human triple-negative breast cancer and adjacent normal tissues 0.86
The multiple myeloma risk allele at 5q15 lowers ELL2 expression and increases ribosomal gene expression [ELL2 rescue] 0.85
Virus Mimicry in the Tumor Microenvironment Activates RIG-I Through Unshielding of Endogenous RNA in Exosomes [RNA-Seq] 0.85
single cell RNA-seq from GM12878 (ENCSR673UIY) 0.84
PRMT5 Interacts with the BCL6 Oncoprotein and is Required for Germinal Center Formation and Lymphoma Cell Survival 0.83
Aging Human Hematopoietic Stem Cells Manifest Profound Epigenetic Reprogramming of Enhancers That May Predispose to Leukemia (RNA-Seq of HSCe) 0.82
Gene expression profiles of 4-1BB+PD-1-high, 4-1BB-PD-1-high, and PD-1-int tumor-infiltrating CD8 T cells in hepatocellular carcinoma 0.79
Chromatin remodeling mediated by ARID1A is indispensable for normal hematopoiesis in mice (human RNA-Seq) 0.79
Zika virus directly infects human peripheral neurons and induces cell death 0.75
Profiling premalignant lesions in lung squamous cell carcinomas identifies mechanisms involved in stepwise carcinogenesis 0.74
A comprehensive single cell transcriptional landscape of human hematopoietic progenitors 0.72
Loss of CREBBP results in H3K27Ac loss at enhancers and gene expression repression in lymphoma cells 0.71
Loss of CREBBP results in gene expression repression in lymphoma cells 0.71
Methylation DNA mediated KLF4 binding activity in glioblastoma cells 0.66
Mitochondrial phosphoenolpyruvate carboxykinase (PCK2) regulates metabolic adaptation and glucose-independent tumor cell growth 0.65
6mer seed toxicity in tumour suppressive microRNAs 0.65
Transcriptome Analysis Reveals Distinct Responses to Physiologic versus Toxic Manganese Exposure in Human Neuroblastoma Cells 0.63
Alterations of the MEK/ERK, BMP, and Wnt/b-catenin pathways detected in the blood of individuals with lymphatic malformations 0.62
Comparative gene expression profiling of MHH-CALL4 cells subject to pharmacological JAK2 inhibitor treatment (ruxolitinib or CHZ868) or shRNA-mediated JAK2 depletion in vitro 0.6
JAK2 is dispensable for maintenance of JAK2 mutant B-cell acute lymphoblastic leukemias 0.6
Comparative Transcriptomic Analysis of Hematopoietic System Across Species by Microwell-Seq 0.59
Mutually Exclusive CBC-Containing Complexes Contribute to RNA Fate. 0.59
single cell RNA-seq from Purkinje cell (ENCSR888LYA) 0.59
Effect of BB608 on Gene Expression in HNSCC Cell Line 0.58
Effect of PDZ domain binding Kinase inhibition using TOPK-32 (called PBKi) on C4-2 cell transcriptome 0.55
Gene expression changes due to PARP knockdown in human cells 0.54
C19ORF66 broadly escapes viral-induced endonuclease cleavage and restricts Kaposi’s Sarcoma Associated Herpesvirus (KSHV) 0.52
Stochastic genome - nuclear lamina contacts are linked to histone H3K9 dimethylation 0.52
Stochastic genome - nuclear lamina contacts are linked to histone H3K9 dimethylation (RNA-seq data) 0.52
Dissecting the single-cell transcriptome network underlying gastric premalignant lesions and early gastric cancer [10x genomics] 0.51
HSB-2 cells stably expressing LDB1 or mutant LDB1 proteins 0.51
An integrative analysis of non-coding regulatory DNA variations associated with autism 0.5
Priming mobilization of hair follicle stem cells triggers permanent loss of regeneration after alkylating chemotherapy 0.5
Complete deconvolution of cellular mixtures based on linearity of transcriptional signatures 0.48
Does osteogenic potential of clonal human bone marrow mesenchymal stem/stromal cells correlate with their vascular supportive ability? 0.47
Transcription elongation regulates genome 3D structure 0.45
Epigenomes and transcriptomes of human monocytes before and after in vivo exposure to Bacillus Calmette-Guérin vaccine 0.45
A stably self-renewing adult blood-derived induced neural stem cell exhibiting patternability and epigenetic rejuvenation 0.43
The contribution of Alu exons to the human proteome 0.41
Genome-wide expression analysis of human hTert immortalized fibroblasts after downregulation of MCM2 & MCM7 0.4
RNA-seq of ASXL2 shRNA KD in SKNO-1 cells 0.39
CD8+ T cells regulate tumor ferroptosis during cancer immunotherapy 0.39
Characterization of EZH2-deficient human embryonic stem cells [ChIP-seq and bulk RNA-seq] 0.38
Identification of altered developmental pathways in human juvenile HD iPSC with 71Q and 109Q using transcriptome profiling 0.37
Transcriptional profiling of SF295 cells following MTF1 knockout by CRISPR/Cas9 0.37
Image based identification and targeting of cancer stem cells in pancreatic adenocarcinoma (PDAC) 0.35
Functional TRIM24 degraders via conjugation of ineffectual bromodomain and VHL ligands [RNA-seq] 0.35
Expression profile of MM.1S tumors folloiwing treatment with bortezomib 0.29
tRNA modification landscape selectively controls mitochondrial translation efficiency in MERRF 0.29
The multiple myeloma risk allele at 5q15 lowers ELL2 expression and increases ribosomal gene expression [ELL2 KO] 0.28
Metastasis in triple-negative breast cancer 0.28
Functional and genomic characterization of a xenograft model system for the study of metastasis in triple-negative breast cancer. 0.28
Transcriptome analysis of V336Y mutant mitochondrial ribosomal protein in human HEK293 cell line 0.28
RNA-seq of cancer cell lines treated with T-025 0.28
RNA-seq analysis of human cardiosphere cells with different tubule supportive potential 0.26
A runaway PRH/HHEX-Notch3 feedback loop drives cholangiocarcinoma (RNA-Seq) 0.26
circNFIB suppresses lymphatic metastasis of pancreatic cancer 0.24
RNA sequencing of 13 T-cell acute lymphoblastic leukemia patients (5 TCRAD-MYC translocated T-ALL_8TAL1-LMO2 T-ALL) 0.24
A Non-Canonical Nuclear Activity Triggered by Small RNAs and Argonaute Proteins in Human Cells 0.23
Dynamic gene regulatory networks of human myeloid differentiation [RNA-seq_siRNA] 0.23
Solid phase chemistry to covalently and reversibly capture thiolated RNA 0.22
RNA-sequencing of tamoxifen-resistant and -sensitive breast cancer cell lines. 0.22
MEF2C phosphorylation is required for chemotherapy resistance in acute myeloid leukemia [mutant MEF2C] 0.22
Single-cell Transcriptomics reveals multi-step adaptations to endocrine therapy 0.21
rG4-seq reveals widespread formation of G-quadruplex structures in the human transcriptome 0.2
Maternal-biased H3K27me3 correlates with paternal-specific gene expression in the human morula 0.2
Total RNA profiles associated with DDX3 wild-type (WT) or R534H variant expression with or without sodium arsenite treatment [RNA-seq] 0.2
Profiles of ribosome-associated mRNAs regulated by expression of wild-type (WT) or R534H variant of DDX3 with or without Sodium Arsenite treatment 0.2
Vitamin C Promotes Apoptosis in Breast Cancer Cells by Increasing TRAIL Expression 0.18
SNHG5 siRNA knock down in HCT116 cells 0.17
RNA-seq analysis reveals endogenous aryl hydrocarbon receptor regulation is highly associated with eicosanoid synthesis and tumor necrosis factor activity in MCF-7 cancer cells 0.17
A MYC/GCN2/eIF2alpha negative feedback loop limits protein synthesis to prevent MYC-dependent apoptosis in colorectal cancer 0.14
Apoptosis enhancing drugs overcome innate platinum resistance in CA125 negative tumor initiating populations of high grade serous ovarian cancer 0.12
Genome Wide Chromatin Mapping of accessibility (ATAC-seq) and H3K27ac histone modifications in CD56bright and CD56dim natural killer cells 0.12
The Small Molecule ISRIB Reverses the Effects of eIF2α Phosphorylation on Translation and Stress Granule Assembly 0.12
RNA-seq data 0.11
Cooptation of tandem DNA repeats for the control of epithelial-to-mesenchymal transition [RNA-Seq] 0.11
Cooptation of tandem DNA repeats for the control of epithelial-to-mesenchymal transition. 0.11
Transcriptome-wide modulation of splicing by the exon junction complex 0.11
The mRNA export receptor NXF1 coordinates transcriptional dynamics, alternative polyadenylation and mRNA export 0.1
Transcriptome profiling of A2M treated A549 Cell Line Samples 0.09
4C-seq of insulin promoter, knockdown of INS promoter activity and Genome-wide maps of chromatin state in EndoC-βH1 Cells 0.06
Viral shRNA Knockdown of INS Promotor Activity in EndoC-βH1 Cells  0.06
Next Generation Sequencing Quantitative Analysis of Wild Type and AML1-ETO Related Fusion Circular RNA (F-CircAE) Knockdown Kasumi-1 Cells Transcriptomes 0.05
Modulation of nonsense-mediated decay by rapamycin 0.05
Dynamics of Proteo-Transcriptomic Response to HIV-1 Infection 0.04
Club cells surviving influenza A virus infection induce temporary non-specific anti-viral immunity 0.02
nELAVL HITS-CLIP in Alzheimer's Disease patients 0.01


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation